Pregnancy outcomes following rubella vaccination: A prospective study in the State of Rio de Janeiro, Brazil, 2001-2002

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 2, 2011, Pages

  Da Silva E Sá, Gloria Regina ^a   Camacho, Luiz Antonio Bastos ^b   Stavola, Mônica Santos ^a   Lemos, Xênia Rawena ^b   De Oliveira, Carlos Alberto Basílio ^c   Siqueira, Marilda Mendona ^b  

^a Health Secretariat of Rio de Janeiro City   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RUBELLA VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CIRCULATION; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; IMMUNE STATUS; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; NEWBORN; PATIENT MONITORING; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RUBELLA; RUBELLA VIRUS; SPONTANEOUS ABORTION; STILLBIRTH; TREATMENT CONTRAINDICATION; TREND STUDY; VIRUS INFECTION; WILD TYPE; BLOOD SAMPLING; LIVE BIRTH; REVIEW; RUBELLA VACCINATION;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BRAZIL; COMMUNICABLE DISEASE CONTROL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; MASS VACCINATION; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RUBELLA; RUBELLA VACCINE; YOUNG ADULT;

EID: 80053422798     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir408     Document Type: Article

References (35)

1. Banatvala JE, Brown DW. Rubella. Lancet 2004; 363:1127-37. (Pubitemid 38452787)
2. Plotkin SA, Reef S. Rubella vaccine. In: Plotkin SA, Orenstein WA eds. Vaccines, 4th ed. Philadelphia: W.B. Saunders, 2004: 707-43.
3. Brasil, Ministério da Saúde Fundacxão Nacional de Saúde, Coordenacxão Geral do Programa Nacional de Imunizacxões. Informe Técnico para a Campanha de vacinacxão contra Rubéola em Mulheres em Idade Fértil. Brasília: Ministério da Saúde, 2001.
4. Reef SE, Frey TK, Theall K, et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 2002; 287:464-72. (Pubitemid 34251985)
5. Lanzieri TM, Segatto TC, Siqueira MM, Oliveira Santos EC, Jin L, Prevots R. The burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000-2001. Ped Infect Dis J 2003; 22:323-9. (Pubitemid 36461033)
6. Tookey PA, Jones G, Miller BH, Peckham CS. Rubella vaccination in pregnancy. Comm Dis Rep 1991; 1:R86-R88.
7. Enders G. Rubella antibody titers in vaccinated and non-vaccinated women and results of vaccination during pregnancy. Rev Infect Dis 1985; 7(Suppl 1):S103-7.
8. Centers for Disease Control and Prevention. Rubella vaccination during pregnancy-United States, 1971-1988. MMWR Morb Mortal Wkly Rep 1989; 38:289-93.
9. Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 2001; 50:1-23.
10. Centers for Disease Control and Prevention. Notice to readers: revised ACIP recommendations for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001; 50:1117-8.
11. Brasil. Ministério da Saúde/CGPNI/Programa Nacional de Imunizacxo ̃es. Anexo 1: Guia para vigilância e acompanhamento de gestantes vacinadas inadvertidamente contra rubéola. Brasília: Ministe rio da Saúde, 2002.
12. Brasil.Ministério da Saúde/CGPNI/Programa Nacional de Imunizacxões. Anexo 2: Guia para vigilância e acompanhamento de recém nascidos IgM1 de mães vacinadas inadvertidamente contra rubéola, suscetíveis no momento da vacinacxão. Brasília: Ministério da Saúde, 2002.
13. Sá GRS, Camacho LAB, Siqueira MM, Stavola MS, Ferreira DA. Seroepidemiological profile of pregnant women after inadvertent rubella vaccination in the state of Rio de Janeiro, Brazil, 2001-2002. Rev Panam Salud Publica 2006; 19:371-378. (Pubitemid 44252351)
14. Brasil/Secretaria de Estado de Saúde do Rio de Janeiro/SUSC/ADIM. Protocolo de atendimento e acompanhamento de recém-nascidos de mães vacinadas inadvertidamente contra rubéola. Rio de Janeiro, 2002.
15. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
16. Donadio FF, Siqueira MM, Vyse A, Jin L, Oliveira SA. The genomic analysis of rubella virus detected from outbreak and sporadic cases in Rio de Janeiro state, Brazil. J Clin Virol 2003; 27:205-9. (Pubitemid 37329342)
17. Jin L, Vyse A, Brown DW. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ 2002; 80:76-7. (Pubitemid 34151513)
18. Bosma TJ, Corbert KM, O'Shea S, Banatvala JE, Best JM. PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 1995; 33(5);1075-9.
19. Norušis, MJ, SPSS, Inc. Statistical package for social sciences version.
20. Sato HK. Estudos dos efeitos da vacina contra rubéola sobre o produto da gestacxão de mulheres vacinadas durante campanha realizada no estado de São Paulo em 2001. Sao Paulo: Faculdade de Medicina/USP, 2005. [PhD dissertation].
21. Will R. Perfil soroló gico de gestantes inadvertidamente vacinadas contra rubéola. Salvador: Instituto de Saúde Coletiva, UFBA, 2005. [Master's thesis].
22. Modlin JF, Herrman K, Brandling-Bennett AD, Eddins DL, Hayden GF. Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women. N Engl J Med 1976; 294:972-4.
23. Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet A 2004; 130:52-4. (Pubitemid 39121561)
24. Ebbin AJ, Wilson MG, Chandor SB, Wehrle PF. Inadvertent rubella immunization in pregnancy. Am J Obstet Gynecol 1973; 117:505-12.
25. Preblud SR, Williams NM. Fetal risk associated with rubella vaccine: implications for vaccination of susceptible women. Obstet Gynecol 1985; 66:121-3. (Pubitemid 15047398)
26. Badilla X, Morice A, Avila-Aguero ML, et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J 2007; 26:830-5. (Pubitemid 47329856)
27. Banatvala JE, Druce A, Best J, Al-Nakib W. Specific IgM responses after rubella vaccination; potential application following inadvertent vaccination during pregnancy. Br Med J 1977; 2:1263-4. (Pubitemid 8215943)
28. Hamkar R, Jalilvand S, Abdolbaghi MH, et al. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine. Vaccine 2006; 24:3558-63.
29. Minussi L, Mohrdieck R, Bercini M, et al. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil. Reprod Toxicol 2008; 25:120-3. (Pubitemid 350299107)
30. Soares RCFR. Seguimento de mulheres grávidas vacinadas inadvertidamente contra rubéola no Brasil em 2001 e 2002. Rio de Janeiro: Escola Nacional de Saúde Pú blica, Fundacxão Oswaldo Cruz, 2005. [Master's thesis].
31. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2:781-4. (Pubitemid 12068990)
32. Cooper LZ. La carga del síndrome de la rubéola congénita. In: Quadros C ed. Vacunas: Prevención de enfermedades y protección de la salud. Washington, DC: OMS (Publ. Cient. Tec. No. 596), 2004; 57-65.
33. MS/SVS/DASIS-Sistema de Informacxões sobre Nascidos Vivos-SINASC. http://tabnet.datasus.gov.br/cgi/tabcgi.exe.sinasc/cnv/nvRJ.def. Accessed 8 January 2007.
34. Hofmann J, Kortung M, Pustowoit B, Faber R, Piskazeck U, Liebert UG. Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy. J Med Virol 2000; 61:155-8. (Pubitemid 30191242)
35. Centers for Disease Control and Prevention. Recommended adult immunization schedule-United States, October 2006-September 2007. MMWR Morb Mortal Wkly Rep 2006; 55:Q1-Q4.